Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience
Anna Czyż(Wroclaw Medical University), Mieczysław Komarnicki(Poznan University of Medical Sciences), Lidia Gil(Poznan University of Medical Sciences), E. Bembnista(Poznan University of Medical Sciences), Magdalena Matuszak(Poznan University of Medical Sciences), Maciej Kaźmierczak(Silesian University of Technology), Adam Nowicki, Dominik Dytfeld, Maria Kozłowska-Skrzypczak(Poznan University of Medical Sciences), Anna Łojko‐Dankowska(Poznan University of Medical Sciences)
Cited by 22
Related Papers
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
|The Lancet Oncology|2019|493
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2022|453
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
|The Lancet Oncology|2021|266